|
LOS ANGELES (AP) - Botox-maker Allergan Inc. said Monday its 2006 sales would be between $2.81 billion and $2.95 billion, reflecting the biomedical company's recent acquisition of Inamed Corp.
Irvine, Calif.-based Allergan maintained its previous guidance for full-year 2006 earnings per share of $3.56 to $3.62, including expected stock-option expenses of 20 cents per share.
Analysts surveyed by Thomson Financial estimate full-year earnings per share of $3.56 on revenue of $2.76 billion.
|